NCT02981719View on ClinicalTrials.gov

Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

October 1, 2016

Primary Completion Date

October 1, 2018

Study Completion Date

October 1, 2020

Conditions
Pancreatic Cancer
Interventions
PROCEDURE

simultaneous gemcitabine and irreversible electroporation

gemcitabine intravenous infusion prior to irreversible electroporation treatment

PROCEDURE

irreversible electroporation

percutaneous irreversible electroporation was performmed for locally advaanced pancreatic cancer.

Trial Locations (1)

510000

FUDA Cancer Hospital, Guangzhou

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02981719 - Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter